Victor N Mivumbi1, Sarah E Little2, Stephen Rulisa1, James A Greenberg3. 1. Department of Obstetrics and Gynecology, National University of Rwanda Faculty of Medicine, Kigali, Rwanda; Department of Obstetrics and Gynecology, Centre Hospitalier Universitaire de Kigali (CHUK), Kigali, Rwanda. 2. Department of Obstetrics and Gynecology, Harvard Medical School, Boston, USA; Department of Obstetrics and Gynecology, Brigham and Women's Faulkner Hospitals, Boston, USA. 3. Department of Obstetrics and Gynecology, Harvard Medical School, Boston, USA; Department of Obstetrics and Gynecology, Brigham and Women's Faulkner Hospitals, Boston, USA. Electronic address: jagreenberg@partners.org.
Abstract
OBJECTIVE: To evaluate the efficacy of ampicillin versus cefazolin as prophylactic antibiotics prior to cesarean delivery in Rwanda. METHODS: In a prospective, randomized, open-label, single-site study conducted between March and May 2012, the effects of prophylactic ampicillin versus cefazolin were compared among women undergoing cesarean delivery at the Centre Hospitalier Universitaire de Kigali, Rwanda. Postoperatively, participants were evaluated daily for infectious morbidity while in the hospital. Follow-up was done by phone and by appointment at the hospital within 2 weeks of delivery. RESULTS: During the study period, there were 578 total deliveries and 234 cesarean deliveries (40.4%). Overall, 132 women were enrolled in the study and randomized to receive either ampicillin (n=66) or cefazolin (n=66). No women were lost to follow-up. The overall infection rate was 15.9% (21/132). The infection rate in the ampicillin group and the cefazolin group was 25.8% (17/66) and 6.1% (4/66), respectively. CONCLUSION: Implementing a universal protocol in Rwanda of prophylactic cefazolin prior to cesarean delivery might reduce postoperative febrile morbidity, use of postoperative antibiotics, and number of postoperative days in hospital.
RCT Entities:
OBJECTIVE: To evaluate the efficacy of ampicillin versus cefazolin as prophylactic antibiotics prior to cesarean delivery in Rwanda. METHODS: In a prospective, randomized, open-label, single-site study conducted between March and May 2012, the effects of prophylactic ampicillin versus cefazolin were compared among women undergoing cesarean delivery at the Centre Hospitalier Universitaire de Kigali, Rwanda. Postoperatively, participants were evaluated daily for infectious morbidity while in the hospital. Follow-up was done by phone and by appointment at the hospital within 2 weeks of delivery. RESULTS: During the study period, there were 578 total deliveries and 234 cesarean deliveries (40.4%). Overall, 132 women were enrolled in the study and randomized to receive either ampicillin (n=66) or cefazolin (n=66). No women were lost to follow-up. The overall infection rate was 15.9% (21/132). The infection rate in the ampicillin group and the cefazolin group was 25.8% (17/66) and 6.1% (4/66), respectively. CONCLUSION: Implementing a universal protocol in Rwanda of prophylactic cefazolin prior to cesarean delivery might reduce postoperative febrile morbidity, use of postoperative antibiotics, and number of postoperative days in hospital.
Authors: Richard Kalisa; Stephen Rulisa; Thomas van den Akker; Jos van Roosmalen Journal: BMC Pregnancy Childbirth Date: 2016-10-21 Impact factor: 3.007
Authors: Lisa M Bebell; Joseph Ngonzi; Joel Bazira; Yarine Fajardo; Adeline A Boatin; Mark J Siedner; Ingrid V Bassett; Dan Nyehangane; Deborah Nanjebe; Yves Jacquemyn; Jean-Pierre van Geertruyden; Juliet Mwanga-Amumpaire; David R Bangsberg; Laura E Riley; Yap Boum Journal: PLoS One Date: 2017-04-13 Impact factor: 3.240
Authors: Joseph Ngonzi; Lisa M Bebell; Yarine Fajardo; Adeline A Boatin; Mark J Siedner; Ingrid V Bassett; Yves Jacquemyn; Jean-Pierre Van Geertruyden; Jerome Kabakyenga; Blair J Wylie; David R Bangsberg; Laura E Riley Journal: BMC Pregnancy Childbirth Date: 2018-06-28 Impact factor: 3.007
Authors: T Nkurunziza; F Kateera; K Sonderman; M Gruendl; E Nihiwacu; B Ramadhan; T Cherian; E Nahimana; G Ntakiyiruta; C Habiyakare; P Ngamije; A Matousek; E Gaju; R Riviello; B Hedt-Gauthier Journal: Br J Surg Date: 2019-01 Impact factor: 6.939
Authors: Stephen Rulisa; Immaculee Umuziranenge; Maria Small; Jos van Roosmalen Journal: BMC Pregnancy Childbirth Date: 2015-09-03 Impact factor: 3.007